Active ingredientProtirelinCat. No. P-P226-001CAS 24305-27-9Family · Pharmaceutical analytical standards
Protirelin
It is the pharmaceutical form of TRH, the hypothalamic hormone that triggers the release of thyrotropin: a small three-amino-acid peptide whose structure was determined in 1969, used in the diagnostic TRH test. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?To find it, the rival teams of Roger Guillemin and Andrew Schally processed a huge number of sheep and pig brains; both claimed priority and in 1977 they shared the Nobel Prize in Medicine.
Go to the active ingredient →Active ingredientProtirelinCat. No. P-P226-001CAS 24305-27-9
Pharmacopoeial impurityProtirelin EP Impurity BCat. No. P-P226-003CAS 50894-61-6
Pharmacopoeial impurityProtirelin EP Impurity CCat. No. P-P226-004CAS 32159-22-1
Pharmacopoeial impurityProtirelin EP Impurity DCat. No. P-P226-005CAS 24769-58-2
Pharmacopoeial impurityProtirelin EP Impurity ECat. No. P-P226-006CAS 53109-32-3No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceD-His-Protirelin CRSEDQM code P3760020Family ProtirelinReference substanceProtirelin CRSEDQM code P3760000Family ProtirelinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.